A phase I trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor-positive metastatic breast cancer
- Cynthia X. Ma
- , Jingqin Luo
- , Michael Naughton
- , Foluso Ademuyiwa
- , Rama Suresh
- , Malachi Griffith
- , Obi L. Griffith
- , Zachary L. Skidmore
- , Nicholas C. Spies
- , Avinash Ramu
- , Lee Trani
- , Timothy Pluard
- , Gayathri Nagaraj
- , Shana Thomas
- , Zhanfang Guo
- , Jeremy Hoog
- , Jing Han
- , Elaine Mardis
- , Craig Lockhart
- , Matthew J. Ellis
- Section of Medical Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Public Health Sciences
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Bursky Center for Human Immunology and Immunotherapy
- DBBS - Computational and Systems Biology
- DBBS - Biomedical Informatics and Data Science
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- DBBS - Molecular Cell Biology
- Brain Tumor Center
- DBBS - Immunology
- Mentorship to Enhance Development in Academia Program
- Section of Stem Cell Biology
Research output: Contribution to journal › Article › peer-review
85
!!Link opens in a new tab
Scopus
citations